Skip to main content

Zapata Quantum to Present Alongside Fortune 500 and Quantum Leaders at Upcoming Investor and Industry Conferences

Written by Customer Service on . Posted in Public Companies.

Executives to share insights and demo platform in keynotes, fireside chats and panels alongside leaders from Airbus, Rolls-Royce, Verizon and more

BOSTON, May 14, 2026 (GLOBE NEWSWIRE) — Zapata Quantum (OTC: ZPTA) (“Zapata”, “Zapata Quantum” or the “Company”), a pioneer in quantum computing application and algorithm development, today announced that Sumit Kapur, CEO, Dr. Jonathan Olson, Co-founder and VP of Strategy and Operations, and other key executives will participate at several upcoming investor and industry conferences.

  • Benchmark/StoneX Quantum Computing Summit, Washington DC
    • On Wednesday, June 17, at 10:40 a.m., Mr. Kapur will lead a fireside chat on the role of software and applications in the next phase of quantum computing. In addition, Mr. Kapur will host one-on-one meetings with institutional investors at the Westin Georgetown in Washington, D.C.
    • Institutional investors that would like to schedule a meeting with Mr. Kapur at the conference should contact their Benchmark/StoneX representative or can email Richard Land of Alliance Advisors Investor Relations at investors@zapataquantum.com.
  • The Economist’s Commercialising Quantum, London
    • On Tuesday, June 16, at 12:15 p.m., Dr. Olson will speak on a panel with leaders from Rolls-Royce and Airbus on the path to commercial quantum advantage.
    • Attendees can also meet with Zapata and demo its Quantum Application IntelligenceTM platform in the conference exhibition.
  • Quantum.Tech World, Boston
    • On Friday, June 26, at 11:30 a.m., Mr. Kapur will deliver a keynote on Zapata’s Nature Biotechnology paper in quantum-enabled drug discovery, developed in collaboration with Dana-Farber Cancer Institute, the University of Toronto and Insilico Medicine. The study was recognized as one of Nature Biotechnology’s Top 10 Papers of 2025 and featured on the cover of the journal’s December 2025 issue.
    • On Friday, June 26, at 3:00 p.m., Dr. Olson will participate in a panel discussion alongside leaders from Verizon, Nestlé, and UK Financial Conduct Authority (FCA) on the convergence of quantum computing, AI and high-performance computing (HPC), and its impact on enterprise workflows.
    • Zapata executives will also host a roundtable discussion on Thursday, June 25, at 12:30 p.m. focused on the strategic questions pharmaceutical companies should be asking as they develop quantum capabilities, applications and long-term roadmaps.
    • Attendees can meet with Zapata team members and learn more about the Company’s Quantum Application Intelligence platform at Booth E4.
  • Quantum, AI, and the Reallocation of Capital, a16z Tech Week Boston
    • On Wednesday, May 27, at 5:30 p.m., Zapata will participate in a session convening investors, operators, and researchers at the intersection of quantum systems, artificial intelligence, and sovereign capital. The event will be held at the Hult Center in Cambridge, MA.
    • Institutional investors interested in participating in this invite-only event can inquire through the event website.

About Zapata Quantum    

Zapata Quantum is a leading hardware-agnostic, pure-play quantum software company focused on accelerating quantum application development. With a portfolio of more than 60 granted and pending patents developed over seven years, Zapata supports applications across cryptography, pharmaceuticals, finance, materials discovery, defense, and more. The Company is the only organization to have participated across all technical areas of DARPA’s Quantum Benchmarking program and has worked with Fortune 500 enterprises and government agencies to translate quantum advances into real-world impact. The Company’s study demonstrating the potential of quantum-enabled drug discovery was recognized as one of Nature Biotechnology’s Top 10 Papers of 2025. Learn more at zapataquantum.com.

Investor Relations Contact:

Richard Land
investors@zapataquantum.com 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.